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Cerebral Palsy
Robert Skelton, '54
Cerebral palsy is one of the ill-understood disease entities,
which haJ· recei11ed very little medical attention in the past. It has
only been in recent years tbat an awakening interest has developed
in the eady treatment and rehabilitation of these patients. In this
article Robert Skelton discusses the etiology, clinical types, diagnosis and treatment of cereb1·al palsy.
palsy by definition is a condition characterized by parC EREBRAL
alysis, weakness, inco-ordination, or any other aberration of motor
function due to pathology in the motor centres of the brain. It must be
differentiated from (1) spinal palsy, e.g. poliomyelitis or that following
transection of the cord; and (2) peripheral nerve palsy, eg. the paralysis
of lead neuritis or severance of a nerve; (3) cerebral involvement which
does not cause motor dysfunction, e.g . mentally deficient children who
are retarded in motor development or children with central deafness or
blindness.
Incidence
Most authorities agree that the incidence of cerebral palsv has been
underestimated in the past. Dr. Winthrop Phelps, of Baltimore, believes
cerebral palsy is a major cause of disability among children, ranking
slightly behind poliomylelitis in incidence.
On the basis of repeated samplings done in New Jersey and Maryland, ~s well as other areas, Dr. Phelps estimates that seven cases of
cerebral palsy per 100,000 population are born every year. On the basis
of these figures it has been computed that there exist 344,000 cases of
cerebral palsy in the United States under the age of 40. Since cerebral
palsy does not occur in epidemic form , similar to polio, the number of
cases remains approximately the same from year to year. It is believed
that better case reporting would very likely increase the known number
of cases.
Of the seven patients born each year per 100,000 population, one
dies before reaching the age of six. Of the remaining six, two are feebleminded becaust> of their cerebral palsy and present a custodial rather
than a rehabilitation problem. In the remaining four, one is so severely
disabled that he must be classified as home-bound, a second suffers only
the mildest handicap, and requires only a minimum of special handling
before he merges into the general child population. These calculations
leave two with handicap!'> of moderate severity who are ~entally normal.
It is these two children who present the greatest problem in physical and
academic education and rehabilitation.
MARcH, 1954
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There are certain factors which predispose to the occurrence of
cerebral palsy. It is found to be more common among premature than
among full term infants. Likewise, it is more common among first
born children and those with heavy birth weights, where prolonged
labour is more frequent. It occurs more frequently in children born to
older women, who have on the average heavier babies; in boys, who on
the average weigh more than girls at birth. It is higher among white
children than coloured, due in part to the average smaller size of the
coloured newborn infant and in part to the lower incidence of Rh
negativity in this race. A racial factor may also possibly exist. There
seems to be no economic, social or geographical predilections for cerebral
p:1lsy.
Pathogenesis
Anoxia and cerebral hemorrhage are the two most important causes
of cerebral palsy, and their pathogenetic relationship will be briefly
reviewed . The brain is highly sensitive to an anoxic state, especially if
prolonged, and it will cause irreparable damage to the nervous tissue
which does not subsequently regenerate. Anoxia is highly selective in
the damag e that it causes. It affects primarily the basal nuclei and/ or
their connections with resu ltant clinical findings of athetosis or involuntary movements.
Actually anoxia plays a dual role causing primary structural damage and a secondary effect on the cerebral vessels by increasing their permeability and fragility with the subsequent development of hemorrhage.
Hemorrhages may also result from direct or indirect trauma to the
brain or may be precipitated by bleeding tendencies, sudden pressure
changes, or vascular spasm. Sites of predilection of brain hemorrhages
in the newborn are in the vicinity of tears in the large veins and sinuses
in the skull and under the meninges. Intracerebral episodes are less
common, but occur in infants where maternal toxemia or hypertension
exists. Occasionally, multiple minute hemorrhages may be seen in the
cortex and subcortical areas . generally as a result of sudden pressure
changes. Most cerebral hemorrhages are in the proximity of cortical
motor areas or the internal capsule, thus the pyramidal tract area is more
likely to be involved and as a result the clinical picture is usually that
of a true spastic.
Precipitating Factors
These may be divided into factors occurring in the:
( 1) prenatal period
{2) natal period
{3) postnatal period.

Prenatal Causes
These may be divided into two classes:
(a) Hereditary or genetic.
(b) Congenitally acquired in utero.
38
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(a) Hereditary (Genetic) CauseJ
These causes include conditions which exist at birth or become manifest soon after birth and which do not become progressively worse.
These are referred to as static causes and many are familial. Spastic
paraplegia in more than one member of a family may be the
result of rudimentary pyramidal tracts. Likewise, atonic diplegias, congenital tremors, familial athetosis and rigidities due to developmental
defects in the basal nuclei or tracts may be genetically transmitted.
Congenital cerebellar defects may result in ataxia. Certain anomalies of
metabolism may be associated with these cerebral defects and may be
familial in nature, an example is phenyl pyruvic amentia. The various
neurocutaneous syndromes due to ectodermal or mesodermal defects
must be included in this group, such as tuberous sclerosis, Sturge-Weber
syndrome, Von Hippel-Linhaus disease and others.
Certain progressive hereditary anomalies must also be considered.
These are not manifest at birth but appear later in life and are
generally progressive. Actually their defects or anlage may be present
at birth. Thus, the various forms of Tay-Sachs disease ( cerebromacular degeneration) or amaurotic familial idiocy may not become
apparent until after the 6th to the 18th month of life or even later. The
periaxial sclerosing degenerations are also progressive hereditary diseases.
Wilson's disease (hepato-lenticular degeneration) and dystonia musculorum deformans must also be considered as hereditary or genetically
initiated. Genetic anomalies may also be precipitated by gonadal
irradiations.
(b) Congenitally Acquired Factors
This refers to those factors not hereditary in character but which are
due to noxae which affects the fetal brain as a result of disease or trauma
to the mother or to the :1terus. These causes may be listed as:
(1) Anoxia
(2) Cerebral Hemorrhage
(3) Infection
( 4) Metabolic Disturbances
(5) Malnutrition
(6) Rh Factor
Anoxia
Any state that interferes with placental circulation is a potential
cause of anoxia, e.g. compression of the umbilical cord between the head
and bony pelvis; kinking of the cord ; threatened abortions or bleeding
during pregnancy; premature separations and infarcts of the placenta;
and decreased maternal blood pressure is also a potential cause of fetal
anoxia.
Cerebral Hemorrhage
May be the result of fetal anoxia, direct trauma to fetus or uterus,
maternal toxemia of pregnancy or blood dyscrasias.
MARCH,
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Any maternal infection, especially with a neurotropic virus, may
involve the fetal brain. Tn infants and children, the brain is more susceptible to viral infection due to a rich supply and higher metabolic rate.
Certain viruses are more likely to cause fetal encephalitis than others.
German measles is the most notorious. Involvement is not limited to the
brain and a child may develop congenital heart disease, deafness, cataracts
or auditory aphasia, as a result of the infectious process. Other viruses
incriminated are, mumps, measles, chicken pox, herpes zoster and
influenza.
The spirochete of syphilis attacks nervous tissue and cerebral
anomalies or active infection may result. These are manifested as a
meningitis or gummata of brain at birth or a latent fo rm of parenchymatous neurosyphilis.
Metabolic Disturbances
Maternal diabetes with the development of hypoglycemia as a result
of (1) insulin reactions, (2) spontaneous falls in blood sugar, (3) maternal liver damage with disturbance in steroid and glycogen metabolism,
will in turn result in a fetal hypoglycemia, which induces fetal anoxia.
Other factors causing damage in children of diabetic mothers include
excessive birth weight, and a predilection for these mothers to develop
toxemias of pregnancy.
Malnutrition and vitamin deficiencies may also be factors. Warkany
has shown that in animals kept on a diet deficient in riboflavin congenital
defects frequently occur in their offspring.

Rh Factor
This factor accounts for some 8]1o of all cases of cerebral palsy now
seen. These cases result in a typical form of athetosis often associated
with deafness and paralysis of extraocular muscles.
Natal Causes
These are classified in two main categories, anoxia, vascular damage
and trauma.
Anoxia may occur as the result of: (1) Mechanical obstruction of the
respiratory tract. (2) Respiratory movements while in the birth canal
with aspiration of mucus or amniotic fluid . (3) Depression of the respiratory centre by drugs such as morphine or some of the barbiturates.
Obstetrical anesthesia may also asphyxiate the fetus. ( 4) Mechanics of
birth: cerebral palsy is more commonly seen in breech deliveries.
(5) Kinking or pinching of the cord. (6) Abruptio placenta, placenta
previa and maternal anemia also are causes of anoxia.
Vascular damage and traumas as causes of brain injury at birth are
physiologic. The strong uterine contractions, and the resistant maternal
40

U.W.O.

M EDICAL JoURNAL

structures cause damage that cannot be avoided. This is especially true
if there is a large baby andj or a small pelvis, and if the labour is prolonged and difficult.
Trauma or mechanical injury to the skull and brain can cause
hemorrhage as well as contusions. The classical example is, of course,
the too strenuous application of forceps by the obstetrician; however, the
obstetrician has been much maligned and such a mechanism accounts
for less than 57< of all cases of cerebral palsy.
Sudden pressure changes in precipitate deliveries or Caesarian sections can cause intracranial hemorrhages. Any condition which results in
fragility of blood vessels may also cause cerebral hemorrhage. These
are said to be seen in premature, debilitated or weak and syphilitic infants which are both debilitated or weak and have their arteries specifically affected by their disease. Hemophilia may be the cause of intracranial damage from bleeding, but more commonly there is a lack of
vitamin K . This can be corrected by the administration of vitamin K
to the mother prenatally.

Post-natal Causes
These include such causes as : (a) Trauma-direct effects from penetrating wounds and secondary effects due to hemorrhage; (b) Infectionsincluding meningitis, encephalitis, and brain abscesses following otitis
media, anesthesia, lung abscess, etc.; (c) Neoplasms; (d) D1'ugs,-induding lead, arsenic and prolonged insulin reaction; (e) Vascular conditionsin children the most common cause of a spontaneous cerebral hemorrhage
is a rupture of a congenital aneurysm of the brain vessels. With senescene,
however, arterial diseases develop with resultant arteriosclerosis and
hypertension. Cerebral thrombosis due to arteriosclerosis, debilitation
and syphilis is seen in older age groups. Vascular embolism where it
occurs in children is generally due to endocarditis. In adults it may often
follow septicemia, dislodgement of postoperative clots or diseases
of the blood vessels. Sudden pressure changes as in Caisson's disease,
exposure to low pressure in high altitude aircraft and blast injuries may
cause minute hemorrhage in the- brain; (e) Anoxia-may arise from respiratory tract obstruction, from strangulation, drowning or carbon monoxide poisoning.
Oinical Differentiation
The correct differentiation of clinical types is of considerable importance so that the correct method of treatment might be instituted and
the eventual prognosis esimated.

(a) Spastic Type
This type makes up 35-407< of all cases seen. Cerebral cortical damage may produce spasticity, flaccidity or both, and most cases consist of
an admixture of spasticity and flaccidity. Rarely is the damage limited
to area 4, which produces almost complete flaccidity, instead of spasticitr
~RCH ,
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to determine which muscles are spastic, flaccid, normal, or normal but
weak due to overstretching and disuse.
The spastic type is a specific condition characterized by increased
muscular tone. Stiffness is the outstanding clinical sign. Voluntary control of these spastic muscles is impaired, especially the finer and more
discrete movements, which are rough and awkward. Extraocular muscles
may be involved and cause strabismus. Swallowing and speech muscles
may be involved as well and may constitute a serious handicap.
There is a tendency for certain spastic muscles to be in more vigorous contraction than other muscles and thus produce certain typical
attitudes which are most noticeable on walking. In the lower extremities hyperactivity of the hip flexors, adductors and internal rotators, knee
flexors and plantar flexors produces the so-called "scissors" gait. In
the upper arm elbow flexors, forearm pronators, flexors of the wrist
and fingers produce a typical attitude. The arm is usually adducted to
the side but on walking may be held in abduction for balance. With
prolonged contraction, the muscles shorten and persistent deformities
result.
Positive physical findings found in spastic types can be explained
on the basis of an exaggerated deep tendon reflex. This phenomenon
is produced by a mild stretching of the involved tendon which in the
true spastic produces a hypercontractility of the muscle due to the loss
of the inhibition affected by the normal cerebral cortex. These muscles
are so affected that the attempted bending of a joint by an agonist throws
the antagonist into a severe contraction, and in this manner, the motion
is blocked. This is referred to as the stretch reflex. The deep reflexes
in the spastic muscles are of course hyperactive and often clonus is
present.

(b) Athetoid T ype
This type is caused by damage to the basal ganglia which permits
release of involuntary impulses from the cerebral cortex that are re·
fleeted in many different types of involuntary motions. These motions
may be rapid or slow, constant or intermittent, or may appear only on
effort. Weird postural positions and attitudes which usually involve
the entire body are produced but in some cases are one sided. It is significant that these involuntary motions cease in sleep. Muscles innervated by the cranial nerves may be involved similarly. AThere is considerable variation in the severity of different cases. In cases of damage to
the base of the brain, constant grimacing may be produced by involvement of the facial and speech muscles leading to the erroneous diagnosis
of mental deficiency.
Tension athetosis may be mistaken for spasticity which is developed
to overcome involuntary actions. This differentiation is extremely im_portant surgically and these patients are referred to as "tension
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athetoids" . The differentiation is made by the absence of a stretch
reflex and the finding in the tension athetoid that the examiner is able
to "shake loose" the tension by rapid passive flexion and extension of
the involved joint. There is less tendency for fixed contractures in the
tension athetoid than in the spastic type.
(c) Ataxic Type
A cerebellar lesion is the cause of the ataxia which is characterized
by a loss of co-ordination. This is due to loss of synchronous muscle
action in response to the change of position of the body. The ataxic
patient retains his sense of balance on falling and will attempt to correct
himself. Inco-ordination is demonstrated by the inability to perform
skilled acts. It is probable that many mild cases go on unrecognized.
In some cases the child may only be noticed to be clumsy and awkward
in playing. No evidence is found in these patients of spasticity or athetosis to account for their inco-ordination.
The muscles of speech, of the trunk, as well as those of the extremities are involved. Thus these patients learn to walk late and are
unable to walk on a narrow base. Their speech is poor due to ataxia of
the tongue. Physical examination shows the typical reeling, unsteady
gait, with wide base, past-pointing, nystagmus, vertigo, and other
cerebellar neurologic signs. The typical ataxic cerebral palsy patient
will improve spontaneously to a relatively greater degree than patients
of the other types and is capable of learning voluntary balance control
through re-education of the motor pathways.
(d) Rigid Type
This type is due to widespread brain damage and is usually associated with severe mental deficiency. It is characterized by loss of
elasticity of muscles, and a lead pipe response to passive movement of a
joint. A sense of stiffness is encountered which is not due to a true
stretch reflex. The patient is apt to lie in an opisthotonic position. Hypertonicity increases when the child is disturbed and relaxation is noted to
some degree on sleeping. The rigidities may be constant or intermittent
and periods of rigidity and relaxation may be the predominant feature.
The reflexes vary but usually are not hyperactive. These cases do not
respond well to treatment.
(e) Tremor Type
This type is also due to a basal ganglia disturbance and is marked
by vibratory, involuntary movements which are usually slow and rhythmical. The tremors may sometimes be present during rest and are apt
to become prominent on activity (intention tremor). Emotional excitement also tends to accentuate the tremors. Many do not seek aid because
the defect is only slight and not disabling. Exercises for relaxation and
development of voluntary control are useful in overcoming these tremors.
Diagnosis in Infancy
The diagnosis of cerebral palsy may not be simple in the immediate
period following birth. After a difficult delivery, the appearance of
MARcH, 1954
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signs are irregular or difficult respirations, a poor cry and difficult nursing. The fontanelles should be examined for signs of increased intracranial pressure. Bloody spinal fluid is suggestive but its absence does
not rule out brain damage.
The absence of clinical signs indicating location of the site of
hemorrhage prevents surgical removal in most cases. In infants deep
tendon reflexes and the Babinski sign are unreliable as are most other
discrete neurologic tests. Pohl states that only 13% of cerebral palsy
cases were recognized as abnormal by the parents during the first month
of life. As the infant progresses in age the diagnosis becomes more
evident. An easy and reliable method is to test the infant for the ability
to hold up its head, which is usually present by 10 weeks of age. This
may not be developed until much later in life in the cerebral palsy
infant. It is helpful to trace a child's progress in development patterns
of the use of upper and lower extremities, speech and intelligence.
These normals can be found in any pediatric text book.
Treatment
Cerebral palsy by definition can of course occur at any age and
must be treated medically or surgically as the case may be. The discussion of treatment will be confined to certain broad generalizations
especially as they apply to the cerebral palsied child.
Treatment must be divided into the specific treatment of the five
separate groups, for the treatment of spastics, athetoids, ataxies, tremors
and rigidity is all very different.
Phelps believes that the basic fundamental of treatment of all types
of cerebral palsy is the fact that the automatic functions such as reciprocal kicking for instance, are not learned. The sooner these automatic
activities can be trained and established, the sooner a child will approach
normal automatic activity.
The task is difficult and results far from encouraging. The continuous change of methods used in treatment is proof alone that it is a
difficult job. The approach is six fold: (1) physical therapy, (2) occupational therapy, (3) speech therapy, (4) braces, (5) drugs, (6) surgery.
One should keep in mind that spontaneous improvement will take
place invariably and continue throughout adolescent years. This is due
to the normal development of the central nervous system during this
period and this must be considered in the evaluation of the effectiveness of any therapy instituted.
Drug Therapy
Drugs play a very small part in the treatment of cerebral palsy.
They are adjuvant therapy used to provide relaxation in order to do a
test or J?le~t 3.:: social sit~ation . The drugs commonly employed are vita-
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mins, sedatives, Prostigmine, Curare, Myanesin, Tolserol, and Myoxerol.
Atropine or Hyoscine are particularly useful in those cases in which
there is tremor and cog-wheel rigidity.
Surgery
In cerebral palsy surgery is only a narrow aspect in a broad program
of care. Earlier literature shows attempts to adopt procedures developed
for polio to cerebral palsy. It has been appreciated that some degree of
success was obtained in the spastic type but not in others.

McCarrol organizes his prerequisites for surgery in the following
four essentials: (1) a sense of balance adequate to permit the patient to
stand and walk without support; (2) little or no athetosis; (3) enough
intelligence to be able to understand and co-operate; ( 4) satisfactory
speech.
In the upper limb, the aim is to improve function and appearance.
This is rarely attained by present day techniques. In the lower extremity
one attempts to improve function and stability.
The surgeon may direct his attention upon the following structures
and attempt to modify them according to the individual's need:
Muscles and tendons may be lengthened or divided to reduce their deforming influence or may be transplanted to reinforce weaker muscles.
Bones may be structurally revised to mechanically improve their function.
N erves may be divided in part or in whole to reduce the activity or spasticity of certain muscles or groups of muscles.
Braces
The two types of braces most commonly used are corrective braces
and control braces.

Control braces can be of great help to athetoids. Their construction must be much sturdier than that of a polio brace, since they must
control the uninhibited movements of the athetoid. If the child wears
a brace for two or three years a fairly well-appearing gait may develop.
The brace may be removed and such a gait will continue for half an hoUJ;
or so only to have the unwanted motions return . Further use of bracing
will eventually lead to increasingly longer periods of time where they
may go brace-free and eventually discard them altogether.
Control braces are also designed for spastics to counteract their
"scissors" gait. These braces must be very rigid through the hips. In the
severe ataxias a similar control brace will aid in keeping a smooth walking pattern and prevent the patient from learning a distorted walk.
The corrective brace is used to prevent deformities developing in
the rather plastic limbs of a growing child due to the abnormal postures
caused by the cerebral palsy.
Braces are used as aids or adjuncts in the rehabilitation of these
children, and should onlybe used when very definitely indicated.
MARCH ; 1954-···
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This consists for the most part of careful training to establish normal automatic functions or re-education of faultily established patterns.
These three spheres are considered by many as the most important aspects
of treatment of the cerebral palsied child. Occupational therapy is to
help the child learn simple skills that normal children are able to perform with little teaching, such as buttoning clothing, tying knots, etc.
On the other hand, the physiotherapist teaches fundamental motions
and functions. The aim is towards developing ability to obtain normal
balance between flexors and extensors, accuracy of joint movement,
relaxation during use of balance function. The development of speech
is of course of immense importance, and it plays a vital role in the rehabilitation program because it allows the child to express himself and
consequently acquire a more pleasing personality. It stimulates mental
growth and improves his chance of becoming a self-supporting member
of society.
Many other problems arise in the care of the cerebral palsied child.
Assistance from psychologists, psychiatrists and social workers, will help
to solve many of the educational recreational, emotional and vocational
difficulties that tend to beset these unfortunate people.
Summary
Cerebral palsy is an aberration of motor function due to pathology
in the motor control centres caused by conditions occurring in the prenatal, natal and postnatal stages of life.
Five general clinical types are described: spastics, athetoids, ataxies,
rigidities and tremor. Treatment varies according to the degree of involvement and the specific clinical type and takes the form of: (1) orthopedic surgery, (2) drug therapy, (3) psychological and social assistance,
( 4) education by special methods, ( 5) opportunities for recreation, social
contacts and objective relationships, ( 6) vocational guidance and training, (7) psychiatric guidance for child and parent.
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Bronchiectasis*
John C. Douglas, M.D.
In recent years, certain changes in the nature of bronchiectasis
and its management have begun to appear, and in this paper
Dr. J. C. Douglas presents the revised picture of this common
disease.
may be defined as a chronic pulmonary disease
B RONCHIECTASIS
characterized by dilatation of the bronchi with destruction of the
normal components of their walls, and usually with chronic infection of
these bronchi and the surrounding lung parenchyma, plus fibrosis and
collapse.
Etiology
Bronchiectasis is believed to follow a pneumonia which has incompletely resolved, often an unrecognized bronchopneumonia complicating one of the childhood infectious diseases. Foreign bodies or tumors
of the bronchus with a pneumonia distal to them will cause bronchial
ectasia. Some cases are undoubtedly congenital, and bronchiectasis may
complicate pulmonary tuberculosis, although most of the latter cases
involve upper lobes and drain well, thus causing few symptoms. Two
factors are generally agreed to be necessary: a necrotizing infection of
the bronchus and bronchial obstruction.
Clinical Picture
Most textbooks still describe the typical case as a sick person,
dyspneic, often cyanosed, having profuse, foul sputum and clubbing of
fingers , giving a history of hemoptysis, and faced with a very poor
prognosis.
The more usual case seen now in practice differs markedly from
that described. He usually gives a history of the onset of symptoms
following a pneumonia or one of the childhood infectious diseases
(especially whooping cough or measles) , commonly during the first few
years of life. Often there have been several pneumonias since onset.
There will be a history of chronic cough, productive of varying
amounts of sputum, usually purulent but seldom foul. There are frequent respiratory infections, resulting in prolonged increases in sputum.
Hemoptysis is relatively rare, as is dyspnea. (In the "dry" or "hemoptoic"
type, hemoptysis may be the first and only symptom.) On examination,
the subject is usually young - in childhood, teens or early twenties- and
does not appear ill, but is more often well nourished and healthy in
appearance. He is usually not dyspneic on exercise and seldom shows
clubbing. Examination of the chest may show no abnormality; when
• Paper read at the Thirteenth Dr. F. R. Eccles Memorial Medical Alumni Lecture, University
of Western Ontario Medical School, London, Ontario, October 7, 1953.
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findings are present, the commonest are a lag at one base, a few rhonchi
andj or moist rales at one base, changing or disappearing with cough.
Less commonly there will be dullness on percussion, shift of the heart
and trachea, and bronchial breathing. Disease of the paranasal sinuses
often coexists.
Less commonly the subject will be older, showing emphysema and
dyspnea. Or an adult may present a short history dating from a definite
pneumonia occuring in adult life.
Investigation
Bacteriology is not much help in diagnosis, but may be invaluable in
therapy. A variety of organisms may be cultured from the sputum, most
of which represent secondary invaders.
Plain ch"est films - Usually, although not always, the P.A. film will
show some abnormality; collapse of a lobe, shift of organs {heart or
diaphragm) , local emphysema, increased markings at one or both bases,
ring shadows or closely grouped bronchovascular markings.
Bronchoscopy- This procedure is not diagnostic, but is often useful
for drainage prior to bronchography.
Bronchography - For this examination, lipiodol is still used most
commonly in this area. This substance (iodized peanut oil) is removed
very slowly and may obscure the lung fields for months after use. Newer
water soluble compounds are corning into use which are rapidly removed and are less viscid; however, in some cases, these have given
violent reactions with severe bronchospasm. No doubt more satisfactory
compounds will be found. The techniques for bronchography comprise
the catheter method (a urethral catheter passed through the larynx into
one main bronchus) , the transglottic method where the oil is dripped
through the anesthetized glottis by means of a curved canula, by means
of a needle through the trachea, or through a bronchoscope (especially
for small children). Anesthesia is usually topical (cocaine or pontocaine)
except in the case of young children, where a general anesthetic is used.
As a rule, one lung is mapped per session. Both lungs should be thoroughly mapped before surgery.
Tests of Pulmonary Function -These are indicated in rare cases where
surgical intervention is contemplated in the face of impaired pulmonary
reserves.
It is important to always bear in mind the possibility of bronchial
tumor or foreign body.

Treatment
Medical Treatment
The most important single feature is probably postural drainage.
This measure is well known, but its _p roper and efficient use is rare.
Bronchoscopic drainage is sometimes indicated when secretions are
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---Bronchiectasis------------------inspissated. Antibiotics, of course, play a major role and it is here that
culture of organisms from the sputum and determination of their sensitivity is important. Aerosol preparations of antibiotics are not now
thought to be more effective than parenteral administrations and seem
to lead to more frequent drug reactions. General health measures are
important - proper food and rest, with avoidance of respiratory infection. Removal to a dry warm climate often accomplishes great improvement in symptoms, but unfortunately is seldom practical for economic
reasons.
Surgical T reatment
This therapy represents the only cure for bronchiectasis. Due to improvements in surgical and anesthetic techniques, the mortality from
lobectomy has fallen to something under five per cent.
An important question is which case is to be subjected to surgery.
Factors which must be considered are: the age of the patient, the extent
of the disease ( unilobular or multilobular), the severity of symptoms,
and the success or failure of medical management. It must not be forgotten that the results following surgery are not satisfactory in many
cases. Symptoms may persist due to coexisting chronic bronchitis or to
residual bronchietatic areas. The long term result in terms of cardiopulmonary function may not be good. Although loss of actual lung
tissue may not be very important, some sequels of intrathoracic surgery
(pleural thickening and diaphragmatic adhesions) may result in severe
loss of function and may even lead to eventual cor pulmonale. Overdistention of the remaining lobe may lead to emphysema. These factors
are, of course, much more important in bilateral surgery.
Prognosis
There has been little written on the prognosis of bronchiectasis
since the advent of antibiotics. A recent article published in a leading
medical journal quoted an 1871 publication to support the grave prognosis of bronchiectasis untreated by surgery. Certainly the prognosis of
this disease, whether medically or surgically treated, has vastly improved
in recent years.
Case Reports
The following case reports illustrate the possibilities for management of two typical bronchiectatic patients:
Case I : A 23-year-old female giving a history dating from childhood of frequent
chest colds in the fall and winter causing prolonged increase in her year-round
purulent expectoration. There was no definite history of pneumonia at onset.
She had an attack of pneumonia at 20 years of age. Her sputum had never been
foul, nor had she ever spat blood. Investigation was instigated by a routine
miniature chest film .
On examination, she appeared well. There was no lag. An occasional musical rhonchus was heard over both lung bases. There was no emphysema or
clubbing of fingers. She denied copious sputum, but when she was instructed
in postural drainage and demonstrated, she produced four or five ounces of
purulent greyish, non-foul sputum. She had no disease of the accessory nasal
MARCH,

1954

49

sinuses. Her bro~chogram showed extensive cylindrical bronchiectasis of both
lower lobes.
For two years she has regularly practised postural drainage and has had
several short courses of intramuscular penicillin for respiratory flare-ups. Her
sputum has been reduced to a minimum, she has gained weight and has had
fewer respiratory infections, and has lost only one day from work.

The reasons for choosing medical management were the mildness
of symptoms, the extensive nature of her disease (bilateral) and the
excellent response to medical management.
Case II: A 30-year-old housewife giving a history of a severe respiratory infection diagnosed as pneumonia at the age of one year, with chronic cough and
sputum present since this attack. She had had severe respiratory infections every
fall and winter, as well as three or four pneumonias since childhood . At least
two of these pneumonias had been on the _left, since she remembered pleuritic
pain. Her sputum was frequently foul. She had never spat blood. She had
been laid up four to five weeks per year and complained of easy fatiguability.
Sensitivity to penicillin had appeared one year previously.
On examination, she was well nourished and did not appear seriously ill,
althoug h pale. Her fingers and toes showed definite clubbing. A lag on inspiration at the left base was present, and coarse moist rales were heard anteriorly and posteriorly at the left base which did not disappear with cough. No
emphysema was evident clinically. No sinus disease was present. Bronchogram
showed gross saccular bronchiectasis of the left lower lobe and lingula.
She underwent a left lower lobectomy and lingulectomy without event.
One year after operation, she was greatly improved, having only slight chronic
cough with a small amount of sputum, usually mucoid. Her general health had
improved, and she no longer suffered frequent severe respiratory infections.

The reason for choosing surgical management was the presence of
a definitely limited disease which was causing deterioration of health.
Summary
Bronchiectasis now shows lowered incidence and a more benign
character, no doubt due to the advent of antibiotics and the more effective treatment of pneumonia.
Much can be done in further lowering the incidence of this disease
by the recognition and proper treatment of pneumonias, particularly
those complicating the childhood infectious diseases.
Many cases will do well on medical management.
Surgical removal of the affected lung tissue provides the only cure,
and should be considered if the disease is limited, if there is an unsatisfactory response to medical management, and if symptoms are severe
and are interfering with general health.
Unsatisfactory results may follow surgery and are due to inadequate
removal of the disease or persisting chronic bronchitis.
Although multilobular surgery can be done now in many cases with
apparent impunity, the state of the patient's cardio-pulmonary function
in five or ten years must be borne in mind. This risk, of course, must be
balanced against the threat to life provided by severe bronchiectasis.
The decision regarding surgery can usually be postponed for a year
during which time a thorough trial of medical management can be made,
particularly since the disease is not progressive.
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Erythromycin
Lazarus

J. Loeb, M.Sc. '54

In this timely review of the literature of one of the newer and
more promising antibiotics, L. f. Loeb discusses the pharmacology
and the therapeutic importance of erythromycin.

HE advent of antibiotics as potent therapeutic weapons in bacterial
T infections
has been one of the outstanding accomplishments of modern
medical research. However, as the antibiotics become more widely used,
their deficiencies and disadvantages become more evident. In order to
overcome their deficiencies, and to fill the gaps not yet covered by the
existing antibiotics, a systematic search is being conducted for new antimicrobial substances. Erythromycin is a recently discovered antibiotic
which has fulfilled the necessary laboratory and clinical requirements
and is now being employed in the therapy of infections caused by Grampositive microorganisms, especially those due to penicillin-resistant strains.
Source
Erythromycin was first described by McGuire et al (1952) as the
product of Streptomyces erythreus (Waksman) isolated from a soil sample
from the island of Panay in the Phillipines.
Physical and Otemical Properties
The original product tested was a filtrate of Streptomyces erythreus
grown in soybean meal-glucose medium in shake flasks. The purified
substance is a whitish crystalline compound which is a base and readily
forms salts with acids. It is slightly soluble in water to the extent of
2 mg. per ml. It is readily soluble in alcohols, acetone and chloroform
and is moderately soluble in ether, ethylene dichloride, and amyl acetate.
Analysis of the dried preparation indicates a probable molecular formula
of C 9 H1s 0 13 and a molecular weight of 766. There is no benzene ring
structure present in the molecule.
Haight and Finland (1952 a, 1952 b) confirmed and extended many
of the original observations of McGuire et al (1952) on the properties of
erythromycin. The crystalline product was stable at room temperature,
while a sterile solution in broth retained its activity when stored for
eight weeks at 4°C or frozen at -25°C. A solution kept at room temperature (25 °C) showed no loss of potency in 24 hours, slight loss after
three days, with deterioration after one week. At 37°C, there was a
decrease in antibacterial activity after 4- 7 days and the solution deteriorated progressively thereafter. Erythromycin is most active in a moderately alkaline medium (around pH 8.0) similar to streptomycin.
Certain chemical substances known to affect the activity of penicillin
and streptomycin did not affect the activity of erythromycin. There was
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---Erythromycin!----------------no erythromycin- inhibiting substance produced by insensitive bacterial
strains. However, erythromycin is destroyed by acidity (below pH 4.0)
as found in the gastric contents of normal patients.
Antimicrobial Activity
Laboratory Studies in Vitro
The antibacterial activity of erythromycin against Gram-positive bacteria is similar to that of penicillin. Strains of pathogenic straphylococci
(Micrococcus pyogenes) appear to be moderately sensitive. Powell et al
(1953) showed that a concentration of erythromycin above 1 microgram
per mi. suppressed growth, while double this concentration was bactericidal. Most strains resistant to penicillin and other antibiotics were
found to be sensitive to erythromycin, and it is with this group of organisms that erythromycin is most useful therapeutically.
Probably the most sensitive organisms encountered in laboratory tests
were strains of Streptococcus pyogenes (Lancefield's group A) and Diplococcus pneumonia. However, stains of viridans streptococci and enterococci (Strep. fecalis) required higher concentrations for growth inhibition.
Erythromycin was very active against strains of Corynebacterium
diphtheriae. McGuire et al (1952) reported that erythromycin had considerable activity against Mycobacterium tuberculosis (H37Rv) in vitro and
in vivo in relatively low concentrations, but this was not corroborated in
clinical trials.
Among the Gram-negative organisms, erythromycin was found to be
quite active against N eisseria gonorrhoea and Neisseria meningitidis. It
was interesting that strains of H emo phi/us influenzae were inhibited at a
concentration of 0.2 ug. per ml ., and it was active at a slightly higher
concentration against Brucella strains. The enteric group of bacteria proved
to be highly resistant to erythromycin. More than 50.0 ug. per ml. were
required to inhibit strains of the coliforms, Salmonella and Shigella. As
would be expected Proteus and Pseudomonas strains were also highly
resistant.
Laboratory Studies in V ivo
These studies paralleled the in vitro results. McGuire et al (1952)
indicated that the protective activity of this antibiotic was related to the
blood levels obtained. Eryhromycin protected mice against 10 LD of
Corynebacterium diptheriae and against injections of psittacosis virus. Powell
et al (1953) were able to protect mice against Hemophilus pertussis.
Erythromycin was effective against meningopneumonitis virus in mice.
In its activity against lymphogranuloma venerum virus, erythromycin
was not as effective as chlortetracycline (aureomycin). The rickettsia of
epidemic typhus in ovo was suppressed. Erythromycin has no effect
against the smaller viruses.
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McGuire et aJ ( 1952) and McGowen et a/ ( 195 3) independently
described the action of erythromycin against animal parasites. This antibiotic was effective in vivo, against Entamoeba histoylytica in rats, and was
also active against Borrelia novyi, Trichomonas vaginaJis, and oxyurid infestation of mice.

Comparison to Other Antibiotics
As the antibacterial spectrum of erythromycin was elicited, studies
were carried on to compare it with the effects of other antibiotics.
Welch et a/ (1952) stated that " erythromycin has a bacterial spectrum
similar to that of penicillin". They noted that erythromycin is more
effective against streptococci and pneumonococci than chlortetracycline
(aureomycin) , oxytetracycline (terramycin) and chloramphenicol. There
is little difference among these in their effects on viruses and rickettsia.
Haight and Finland (1952a) noted that erythromycin was less active
than the " broad spectrum" antibiotics against the enteric group, but had
similar activity against Hemophilus. Erythromycin probably is most closely
related to carbomycin but inhibited test organisms in lower concentrations. The most striking contrast of erythromycin in other antibiotics
was that strains of staphylococci resistant to penicillin and the "broad
spectrum" group were sensitive to erythromycin.
Mode of Action
At present the information regarding the mode of action of
erythromycin is sparse. Heilman et a/ noted that erythromycin is bactericidal for sensitive stains but its action is not rapid. Erythromycin
may be either bacteriostatic or bactericidal, depending on the sensitivity
of the organism and on the concentration of the antibiotic. It exerts its
effect most readily against rapidly multiplying bacteria.
Development of Resistance
Resistance of Staphylococci against erythromycin could be induced
in vitro according to McGuire et a/ but it was a gradual process, as that
with penicillin. Haight and Finland (1952 d) stated that staphylococcal
resistance could be induced to 100 mg. per ml. rapidly while resistance
of streptoccocci was induced after many more transfers.
Resistance in vivo occurred in strains of staphylococci, enterococci, and
viridans streptococci after contact with the drug. There are few reports of
naturally resistant variants of sensitive strains. Kirby, Forland and Maple
(1953) noted that only 2% of penicillin resistant staphylococci are not
affected by erythromycin.
Cross resistance was not encountered between erythromycin and
other antibiotics except carbomycin. Finland et aJ (1952) noted that
repeated subculture of staphylococci and of certain strains of streptococci in the presence of increasing concentration of either erythromycin
or carbomycin results in fairly rapid and marked increase in resistance
to both antibiotics.
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---Erythromycin-----------------Pharmacological Properties
ABSORPTION
Oral Administration
When administered orally to patients and test subjects, erythromycin
was absorbed but there was much variability in the blood levels obtained.
Heilman et al (1953) reported that a dose of 0.75 gm. to 1.0 gm. given
to patients resulted in adequate serum levels within three to four hours.
Good levels were also obtained using 0.4- 0.5 gm. which gave less gastrointestinal irritation, but the serum concentration began to decline after
four to six hours. Josselyn and Sylvester (1953) noted that erythromycin
is readily absorbed in the upper gastro-intestinal tract, however, absorption was lessened or destruction was increased by gastric acidity and
digestive enzymes in normal subjects. Higher blood levels were obtained
in subjects with achlorhydria, for example, those having pernicious
anemia.
Kirby et al (1953) showed that coated tablets which resisted acid
solution, disintegrated in from three to five minutes at pH 7 or higher
and a dose of 0.5 gm. gave low blood concentrations for the first three
to four hours, but many patients had adequate blood levels within two
hours. The serum concentrations were over 1 ug. per ml., many between
10- 20 ug. per ml. where patients received multiple doses. The blood
levels were higher than those obtained on similar dosage levels with
chlortetracycline or oxytetracycline and were comparable to the administration of 2 - 3 million units of penicillin.
Special forms of erythromycin have been developed for oral administration to children where tablets cannot be given. Sylvester and Josselyn (1953) reported on "Erythromycin stearate" prepared in an aqueous
vehicle containing carboxyl methylcellulose as a suspending agent with
sodium citrate as a buffer. This agent resisted destruction by gastric
secretions and was readily absorbed. Blood levels were obtained which
were in the range of in vitro sensitivity of susceptible organisms. The relationship of meals bad little or no effect on serum concentration. A more
recent product is "Ilotycin (Erythromycin, Lilly) Ethyl Carbonate" which
consists of dry granules to which water is added so that 5 ml. contains
100 mg. of erythromycin. This suspension is not affected by gastric
acidity and remains stable at room temperature for two weeks.

Intravenous Administration
Maple et al (1953) described the use of erythromycin given intravenously in a dose of 0.5 gm . in 200 ml. of saline solution, over a 30
minute period, gave a high initial blood concentration of from 7 - 30
ug. per ml. Thereafter, the concentration fell rapidly and at six hours
ranged from 0.1- 1.0 ug. per ml. Adequate therapeutic concentrations
were present when 1.0 gm . of erythromycin was administered as a continuous I.V. saline drip over a six hour period. Virtually no side reactions were encountered. Martin et al (1953) used an average dose of
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250 mg. of erythromycin dissolved in buffered saline solution and administered intravenously every six to eight hours. This method of administration was found useful where a high initial concentration was
required and for patients unable to take the antibiotic orally.

Topical Application
Livingood et al (1953) described the use of a 0.5«fo erythromycin ointment for Gram-positive infections of the skin. Very few patients had
sensitivity or irritant reactions, but the drug was not well tolerated by
denuded or eczematized skin. A 1«fo erythromycin ointment in a base of
petrolatum and 5«fo heavy mineral oil was used by Robinson and
Zeligman (1953) and no sensitivity reactions were encountered in 47
patients. This antibiotic product proved successful in the treatment of
pyogenic infections of the skin. However, Martin et al (1953) believe
that ointments which contain erythromycin may cause an increase in the
incidence of resistant strains of bacteria normally found on the skin, and
did not advocate its use in this form.
Concentrations in Body Fluids and Tissues
The concentration of erythromycin in blood serum varies with the
dosage given and other factors mentioned under absorption. For effective therapeutic dosage a blood concentration of from 5 to 10 ug. per ml.
is optimum. The recommended dosages will be discussed subsequently.
Erythromycin does not diffuse readily into the cerebrospinal fluid.
When there was a therapeutically effective level in the blood serum less
than half the patients examined had more than a trace in the C.S.F.
Grigsby et al (1953) remarked that the irregular appearance of erythromycin in the C.S.F. in meningitis would be inadequate to clear the
infection.
Heilman et al (1953) showed that erythromycin is present in the
fetal circulation when therapeutically effective levels are present in the
mothers serum. This is similar to penicillin and other antibiotics which
traverse the placental barrier readily.
Erythromycin apparently is present in a pleural effusion during
adequate therapy and may be of value in the treatment of infections of
the pleural cavity. Grigby et al (1953) showed that erythromycin also
diffuses into ascitic fluid. Other studies have indicated that erythromycin
diffuses rather readily and uniformly into most of the body tissues.

Excretion
Heilman et al (1952) studied the presence of erythromycin in the
bile of patients having a tube in the common bile duct with normal liver
function. They showed that erythromycin is concentrated in the liver
and is excreted readily in the bile in a biologically active form. This
contributes to the large amount of th~ drug found in the feces .
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---Erythromycin-----------------Haight and Finland (1952 a) reported that the amounts of erythromycin found in the urine appear to be smalL and erratic after ingestion
of a single or repeated small doses of the drug, especially early in the
therapeutic course. After continuous therapy with divided doses, up to
15% of the amount ingested daily could be demonstrated in active form
in the urine.
Large amounts of erythromycin have been recovered from feces.
Oral administration and bile excretion contribute to the high concentration . The presence of erythromycin has a definite effect on the bacterial
flora of the Gram-positive flora with the elimination of species of
Clostridium from the feces. Martin et al (195 3) noted that the elimination
of Clostridia accounts for the odorless fecal specimens obtained from
patients receiving erythromycin orally for several days. There is no
appreciable effect on the coliforms or enterococci present. Erythromycin
has been found to be effective in treating cases of staphylococcal enterocolitis which may occur and be the cause of severe diarrhea which
ensues after oral therapy with the " broad spectrum" antibiotics (Dearing
and Heilman, 1953) .
Toxicity
The toxic effects of erythromycin therapy are remarkably low.
Clinically, patients given 0.75- 1.0 gm . orally by Heilman et aJ (1953)
often experienced gastro-intestinal irritation, including nausea, vomiting
and occasionally diarrhea. Generally there was a lack of serious toxicity
in the usual dosage range of from 0.3 to 0.5 gm. per dose. No tendency
to develop avitaminosis during oral therapy was encountered, nor any
indication of the development of secondary moniliasis as a therapeutic
complication.

Oinical Application
Dosage
The oral dosage originally outlined by Heilman and his colleagues
has been only slightly modified in present day therapy. They recommended 0.4 -0.5 gm. every six hours, reduced to 0.3 gm. if signs of
toxicity become evident. Recently, Smith et aJ (1953) used 0.3- 0.5 gm.
every six to eight hours, giving an overall daily dosage from one to
two grams.
Indications
Erythromycin has been found to be very useful in the treatment of
staphylococcal infections and gave good results in cases of septicemia,
pyoderma, etc. Kirby and Ahern (1953) , echoing the remarks of others
stated, "of the three antibiotics available for the treatment of resistant
staphylococci- erythromycin, chloramphenicol and bacitracin - erythromycin is the agent of choice because of the bactericidal action against
staphylococci, and its low degree of toxicity" . It was noted that the response to therapy is comparable to that observed with penicillin in infections caused by penicillin - sensitive strains.
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Resistant strains of staphylococci, when present in the intestinal
tract in large numbers, may produce varying degrees of gastro-intestinal
and systemic manifestations. The stools of some patients who developed
diarrhea after chlortetracycline and oxytetracycline therapy contained
M. pyogenes in pure culture. Cases of subsequent fatal enterocolitis and
septicemia have been reported. Dearing and Heilman (1953) showed
that erythromycin (300- 400 mg . four times daily, orally) is capable of
elimination of these resistant strains and the alleviation of untoward
gastro-intestinal or systematic reactions.

In the therapy of infections due to Streptococcus pyogenes (Group A),
Heilman, and Haight and Finland reported good clinical response. Some
strains of enterococci and viridans streptococci were not effectively dealt
with, since erythromycin was not bactericidal in these cases and some
organisms became resistant during the course of therapy. In an overall
evaluation, Finland ( 1953) stated that in streptococcal infections
erythromycin is less effective than penicillin.
A generally good response of pneumococcal infections was reported
by Haight and Finland (1952 a). The clinical effect was similar to that
with sulphadiazine and other antibiotics; a definite improvement was
noted in 24- 48 hours. However, in a report on twelve patients with
pneumococcal pneumonia, Burn and Cook (1953) reported a good response in five patients while seven patients showed slow resolution or
failed to respond . It was concluded that "erythromycin is not the drug
of choice for pneumococcal pneumonia".
Heilman reported on a case of Hemophilus influenzae pharyngitis
successfully treated with erythromycin.
In the therapy with erythromycin Grigsby et al (1953) showed that
three-fourths of the cases of acute gonococcal urethritis in females responded well, but Haight and Finland (1952 a) concluded that the
results were not as good as with penicillin. Anderson (1953) reported
on a case of meningococcemia where the organism was resistant to penicillin and oxytetracycline. Erythromycin was found to be effective on
the basis of sensitivity tests and proved successful clinically.
There have been a few other reports of clinical trials with erythromycin, but new therapeutic results will be reported soon on experiments
now in progress. Generally, the consensus of opinion is that erythromycin
will be useful in patients with penicillin sensitivity or in infections
caused by penicillin resistant strains of bacteria. In the pneumonias
erythromycin should be kept in reserve for penicillin - treated cases
with poor results.
Development of Resista11ce
Cases of staphylococcal osteomyelitis reported by Heilman et al {1953)
and Kirby et al (1953) did not respond well to erythromycin therapy. On
subsequent laboratory testing it was found that the organism developed .
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---Erythromycin-----------------resistance to erythromycin in a high concentration. This pointed to the
selection of a mutant rather than gradual increase in resistance during
therapy. Finland ( 1953) noted that the failures encountered in patients
with endocarditis were associated with the development of resistance
in the strains of staphylococci and enterococci during treatment. In the
routine testing for antibiotic sensitivity in the bacteriology laboratory
at Victoria Hospital, London, the writer found that approximately 101o
of staphylococcic strains were resistant to erythromycin. Most of these
were resistant to other antibiotics: penicillin, streptomycin, chlortetracycline and oxytetracycline, but not to chloramphenicol.
Combined Therapy
The use of antibiotics 10 combination has been of some value in
enhancing their individual effects and decreasing their toxic side reactions. Finland (1953) noted that the combination of erythromycin
with penicillin or streptomycin may increase their activity and delay or
prevent the development of resistance. The use of erythromycin with
streptomycin was recommended to widen the range activity to include
Gram-positive and Gram-negative organisms when erythromycin is substituted for penicillin in penicillin-resistant infections. Powell et al
{1953) found that synergism was apparent between erythromycin and
sulphadiazine in experimental streptococcal infections in mice. This has
been corroborated in clinical experiences with this combination.

Summary and Conclusions
1. Erythromycin is a recently discovered antibiotic produced by
Steptomyces erythreus. It is a crystalline, basic substance slightly soluble
in water, which is readily put into solution with a small amount of
alcohol, to which water or saline are then added . This antibiotic is most
active in a slightly alkaline medium.
2. The "antibacterial spectrum" of erythromycin includes Grampositive organisms: staphylococci, streptococci, pneumococci, clostridia,
and corynebacteria and a few Gram-negative bacteria: Neisseria, Hemophilus and Brucella strains. It has some activity against the psittacosislymphogranuloma group of virus. Entamoeba histolytica and some other
animal parasites appear to be sensitive to erythomycin. This range of
organisms justified the designation of a "medium-spectrum" antibiotic.
Erythromycin has a similar but quantitatively more effective action than
carbomycin, these two antibiotics exhibit cross resistance.

3. Erythromycin is usually given orally. It is partially destroyed
by gastric acidity, but acid-resistant tablets are absorbed well in the upper
intestine. The usual dose for adults is 200 - 400 mg. every six hours.
Only minor gastro-intestinal upset has been reported in a few cases. The
antibiotic diffuses readily through most body tissues with the exception
of the cerebrospinal fluid especially where the meninges are inflamed.
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It is concentrated and excreted in the bile, and large amounts are excreted
in the urine. Erythromycin can be used intravenously without any systemic toxic reaction.
4. The main clinical use for erythromycin is in the treatment of
infections attributable to strains of Micrococcus pyogenes (staphylococci)
that are or may become resistant to penicillin or other commonly employed antibiotics. Only a small number of staphylococci are resistant
to erythromycin, but in some instances of chronic infection the organisms may become resistant rapidly. The combination of erythromycin
with other antibiotics may prevent or delay development of resistance
or may widen the range of effectiveness. Erythromycin is useful in cases
of staphylococcal enterocolitis especially after therapy with broad spectrum antibiotics. The action of erythromycin against other bacteria has
been discussed . This antibiotic may be useful in patients who are allergic
to penicillin or in cases where the toxic effects of other antibiotics should
be avoided .
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Rheumatoid Arthritis:
Douglas Boclcing, M.D.
Although the etiology and pathogenesis of rheumatoid arthritis remain obscure, significant advances in the management of
this most crippling form of arthritis have been made in recent
years. In this paper, Dr. D. Bocking discusses various methods
of management of the patient which are of proven value, or are
of value in selected cases as welt as methods, which are of doubtful or no value.
importance of rheumatoid arthritis lies not only in its potential
T HEdevastating
effect on the joints and general well-being of the
patient, but also in the serious consequences on the social and economic life of the individual, family, community, business and industry.
When one considers that cases of rheumatoid arthritis comprise approximately one third of those attending rheumatic disease clinics, its importance is further emphasized.
Although many theories have been advanced to explain the etiology
of rheumatoid arthritis, no comprehensive hypothesis which embraces
all the known facts has yet been proposed. Among the more popular
theories have been the infectious, metabolic, endocrine, neurogenic,
psychogenic, and allergic. Despite its uncertain causation, a few facts
have been established fairly definitely, which may shed some light on
the disease mechanism. Among these known factors are:
(1) a sex preponderance of 3:1 in women,
(2) an average age of onset of approximately 40 years, although it may
begin in infancy or after 70,
(3) a definite familial tendency,
( 4) an amelioration by pregnancy, or jaundice, and
(5) peripheral vascular abnormalities in the form of excessive perspiration
of the hands and feet, and Raynaud's phenomena of the fingers, which
frequently precedes the onset of arthritis.

The following may be of significance as precipitating or aggravating
factors:
{1) trauma,
{2) physical stress,
{3) emotional stress, or
(4) cold and damp weather.
In addition to an awareness of the above-mentioned possible etiological and precipitating factors, the attending physician should be prepared to advise the patient on the posible future course of the disease.
The patient and relatives commonly envision a gradual progression to
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severe crippling, complete invalidism, and a bed or wheel-chair existence. Fortunately, only about 101j'0 of cases of rheumatoid arthritis follow such a progressive downhill course. Another 15 to 201j'o have a
solitary attack followed by complete remission. The remainder run a
prolonged fluctuant course characterized by spontaneous exacerbations
and remissions. It is important that both physician and patient be aware
of the natural course of rheumatoid arthritis in order to avoid either
undue optimism or excessive pessimism. As with any chronic disease,
these patients require a great deal of encouragement and reassurance.
An optimistic attitude is of inestimable value in their successful management.
The actual methods employed in treatment can only be considered
briefly in this paper. It is important to realize that each patient must
be treated individually, depending on the severity, activity, and duration
of the disease, and the site of joint involvement. Treatment can be
considered under the following headings:
I. Methods of Proven Value.
II. Methods of Value in Selected Cases.
III. Methods of Doubtful or No Value.
I.

Methods of Proven Value
1. Rest:
The importance of adequate rest cannot be over-stressed. During
the acute phase, complete bed rest may be required, whereas later the
amount of rest may be decreased gradually.
2. Physiotherapy :
Exercises and heat are extremely important and their main objectives are to prevent joint deformities maintain joint motion, and to preserve muscle strength. During the acute inflammatory phase, passive
and active assisted exercises are commenced. As the arthritis improves,
resistance exercises are instituted. A balanced program of exercise and
rest for the involved joints is thus arrived at for each patient. The importance of quadriceps exercises cannot be over-stressed when the knee
joint is involved.
3. Salicylates:
These are still the best drug in the over-all management of rheumatoid arthritis. They should be prescribed in adequate amount-e.g. 4.0
to 7.0 gm. daily. Experimental work now suggests that they exert an
anti-inflammatory effect in addition to their analgesic action. Toxicity
does not result from average therapeutic doses, and gastric irritation
may be avoided by the use of buffered or enteric-coated pills. Codeine
and other "pain-killers" should be prescribed seldomly because of the
danger of addiction in chronic illness.
4. General supportive therapy:
The diet should be adjusted so as to restore these patients to their
" ideal" weight, and supplementary vitamins may be prescribed. The
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---Rheumatoid A r t h r i t i s - - - - - - - - - - - - - hypochromic anemia, which is observed frequently in rheumatoid arthritis, often does not respond to oral iron medication. Intravenous iron
therapy may be of value in certain cases, but should be used with caution. Blood transfusions also may be extremely beneficial.

•

5. Psychotherapy:
This is extremely important in treating these patients. Genuine
and kindly interest, encouragement, and reassurance by the attending
physician are of far more value in most cases than psychoanalytic interviews. Both patient and family require help in readjusting their lives
to one of chronic illness. A trained social worker may be of real assistance in this aspect of treatment.
6. Orthopedic Measures:
The insidious development of deformities, notably ulnar deviation
of the fingers and flexion contractures of the knees, can be prevented
to a large extent by the early use of plaster casts. These should be worn
at night and during periods of rest in the day. The use of pillows under
the knees contributes to knee deformities and should not be allowed.
Complete immobilization of rheumatoid joints may be disastrous, with
the rapid development of fibrous or bony ankylosis. Moving the joint
through a full range of motion daily prevents the formation of fibrous
adhesions. Other non-surgical measures include crutches, canes, braces,
etc.
Various surgical procedures have been developed. The most satisfactory results have been obtained with arthroplasty of the elbow, or
hip, acromioplasty, and metatarsal head resection. Usually these procedures shoud be withheld until the disease is relatively inactive or
apparently "burnt out".
7. Rehabilitation:
Measures employed in rehabilitating patients with rheumatoid arthritis comprise one of the most important phases of treatment. Success
depends upon the team-work of patient, nurse, physiotherapist, occupational therapist, social worker, orthopedic surgeon, and physician, the
latter directing and co-ordinating the concerted efforts. It is best to
set limited and obtainable objectives, and to re-assess the individual case
frequently in order to evaluate progress and possible future goals. Unfortunately due to the natural course of the disease, valuable gains may
be vitiated by an exacerbation of the arthritis. Nevertheless, these
patients are extremely grateful for even relatively slight advances, e.g.,
ability to use crutches rather than being confined to wheel-chair or bed.
Sheltered work shops or training courses for new occupations may be
indicated also.

II.

Methods of Value in Selected Cases
1. Chrysotherapy:
This has not yet been accepted by all authors as being of proven
value in the therapy of rheumatoid arthritis. Many workers feel that
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the high incidence of toxic reactions does not warrant its use. Hench
and others, however, feel that gold therapy is justified if the disease is
still progressive despite an adequate trial of conservative management.
Aqueous preparations of organic gold salts are preferable and the usual
intra-muscular dose is 25 to 50 mg. weekly, after one or two smaller
initial doses. After completing a course of 1000 mg., it appears preferable to give a maintenance dose of 25 to 50 mg. every three or four
weeks. Signs or symptoms of toxic effects should be watched for carefully- e.g., thrombocytopenia, agranulocytosis, aplastic anemia, dermatitis, stomatitis, and nephritis. The patient should have frequent hemoglobin, W.B.C., differential, and platelet estimations as well as urinalyses. If signs of a toxic reaction appear, the gold therapy should be
stopped immediately. BAL and cortisone are now available for treatment of the serious complications. Splenectomy is often of value in
cases of thrombocytopenia due to chrysotherapy.
2. Cortisone and ACTH
Since the original discovery in 1948 by Hench and his co-workers
of the dramatic and ameliorating effects of cortisone and ACTH on
rheumatoid arthritis, the initial enthusiasm has been supplanted now by
more careful selection of cases for this therapy. These agents suppress
the active inflammatory process in the synovial membrane and other
tissues, but exert no curative effect. The actual mechanism of the antiinflammatory action of cortisone is still unknown. It is obvious that
cortisone will have no effect on the late stages of rheumatoid arthritis
when there is fibrous or bony ankylosis of joints.

Cortisone therapy should not be used for every case of rheumatoid
arthritis, but reserved for the patient who is not improving, or shows
progressive disease, despite adequate conservative therapy. At present
the main contra-indications are active peptic ulcer, psychosis or severe
psychoneurosis, active infection, e.g . tuberculosis, severe hypertension,
diabetes mellitus, cardiac or renal failure. These conditions are not all
absolute contra-indications and their relative importance must be balanced against the severity of the arthritis.
Whereas previously large initial doses of cortisone were recommended, most clinics now favour starting treatment with smaller initial
doses and gradually increasing to a satisfactory maintenance dosage.
Experience now suggests that a "safe" maintenance dosage for long
term treatment should not exceed 50 mg. daily for women or 75 mg.
daily for men. Larger dosage schedules will result in most instances
in the development of Cushingoid features and an increased incidence
of serious side effects. Withdrawal of cortisone should be done gradually by 5 or 12.5 decrements. Hydrocortisone is now available for oral
use. Compared with cortisone, a smaller dose of hydrocortisone is
frequently effective and there is reputedly less sodium retention effect.
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---Rheumatoid A r t h r i t i s - - - - - - - - - - - - - Patients receiving cortisone must be followed carefully with respect
to disease activity, symptoms of possible complications, signs of hypercortisonism, weight, blood pressure, urinalysis, and chest X-ray. If
peripheral edema develops, it is usually controlled by salt restriction,
supplementary potassium chloride, and mercurial diuretics.
There is considerable evidence now to indicate that prolonged
administration of cortisone results in temporary adrenocortical depression. At times of added stress, e.g. severe infection ,operations, or
burns, relative adrenal insufficiency may develop and should be controlled by much larger daily doses of cortisone, e.g. 100 - 200 mg.
Prolonged maintenance therapy with ACTH which is given intramuscularly or intravenously, is usually not practical. It may be used,
however, during exacerbations of the disease, or to stimulate the adrenal
cortex while on prolonged cortisone therapy.
3. Intra-articular Hydrocortiso11e:
In selected cases, where infectious arthritis has been excluded, the
intra-articular injection of Compound F may be beneficial. The usual
indications are:
(a) Active inflammation in one or two joinst accessable to injection.
(b) In conjunction with systemic cortisone when one or two joints
continue to be involved actively.
(c) In conjunction with orthopedic procedures, e.g., joint manipulation, wedging of casts, or arthroplasty.
The results and duration of improvement are unpredictable. The usual
dose ranges from 12.5 to 50 mg. ,depending on the size of the joint.
4. Irradiation:
Deep X-ray therapy is of little value in the peripheral form of
rheumatoid arthritis but is often beneficial in cases of Marie-Strumpell
Spondylitis.
5. Phenylbutazone ("Butazolidine" )

This drug has undergone extensive clinical trials during the past
four years. Its ultimate place in the management of rheumatoid arthritis is still in doubt. In addition to an analgesic action, it also
apparently exerts an anti-inflammatory effect. The average maintenance
dose is from 300 to 600 mg. daily. Benefit, if it occurs, is usually apparent
within a week to ten days. The risk of certain serious toxic effects
must be weighed carefully against the possible therapeutic benefits. The
most serious complication is agranulocytosis which has resulted in
fatalities in a few reported instances. Other toxic effects include gastrointestinal irritation, edema; dermatitis, thrombocytopenia, and aplastic

anemia.
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Methods of Doubtful or No Value
The number of drugs and other therapy employed in the treatment
of rheumatoid arthritis is legion. Space does not permit a discussion of
these but a few may be listed, e.g. vaccines, antibiotics, foreign proteins,
vitamin D , removal of foci of infection, post partum plasma, etc.
ill.

Conclusion
The management of rheumatoid arthritis has been outlined briefly,
with particuar emphasis on the importance of a sound basic program
of conservative measures. This may be supplemented in selected cases
with cortisone or ACTH, intra-articular hydrocortisone, gold, or irradiation (in cases with spinal involvement). Although no cure is
available yet, the results of the above treatment are often extremely
g ratifying to the patient, the members of the family and the physician.
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Advertisement
WANTED- Young psychiatrist for large, private psychiatric hospital
situated in Southern Ontario. New residence available on hospital
grounds. Good salary and full prerequisites. Apply "Wanted-Psychiatrist, c/o U.W.O. Medical Journal, University of Western Ontario,
London, Ontario.
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